Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. [L'application topique de médicaments anti-fibrinolytiques pour la chirurgie cardiaque avec circulation extra-corporelle : analyse méthodique et méta-analyse.] [English, French abstract] (odpre novo okno)

Abrishami A, Chung F, Wong J.

Vir‎: Can J Anaesth 2009;56(3):202-12.

Indeksirano‎: PubMed 19247741

DOI‎: 10.1007/s12630-008-9038-x

https://www.ncbi.nlm.nih.gov/pubmed/19247741 (odpre novo okno)

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. (odpre novo okno)

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

Vir‎: Heart Lung Circ 2012;21(11):706-10.

Indeksirano‎: PubMed 22842057

DOI‎: 10.1016/j.hlc.2012.06.016

https://www.ncbi.nlm.nih.gov/pubmed/22842057 (odpre novo okno)

Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. (odpre novo okno)

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L.

Vir‎: J Cardiothorac Surg 2009;4:25.

Indeksirano‎: PubMed 19538741

DOI‎: 10.1186/1749-8090-4-25

https://www.ncbi.nlm.nih.gov/pubmed/19538741 (odpre novo okno)

Current status of pharmacologic therapies in patient blood management. (odpre novo okno)

Goodnough LT, Shander A.

Vir‎: Anesth Analg 2013;116(1):15-34.

Indeksirano‎: PubMed 23223098

DOI‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 (odpre novo okno)

The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. (odpre novo okno)

Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.

Vir‎: Anesth Analg 2009;109(1):15-24.

Indeksirano‎: PubMed 19535691

DOI‎: 10.1213/ane.0b013e3181a40b5d

https://www.ncbi.nlm.nih.gov/pubmed/19535691 (odpre novo okno)

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. (odpre novo okno)

Howell N, Senanayake E, Freemantle N, Pagano D.

Vir‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

Indeksirano‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 (odpre novo okno)

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. (odpre novo okno)

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

Vir‎: Anesth Analg 2010;110(1):21-9.

Indeksirano‎: PubMed 19910626

DOI‎: 10.1213/ANE.0b013e3181c0ea6d

https://www.ncbi.nlm.nih.gov/pubmed/19910626 (odpre novo okno)

Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion. (odpre novo okno)

Mansouri M, Attary M, Bagheri K, Massoumi G, Ghavami B.

Vir‎: Interact Cardiovasc Thorac Surg 2012;15(1):23-7.

Indeksirano‎: PubMed 22514257

DOI‎: 10.1093/icvts/ivs114

https://www.ncbi.nlm.nih.gov/pubmed/22514257 (odpre novo okno)

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. (odpre novo okno)

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

Vir‎: J Thorac Cardiovasc Surg 2006;132(3):475-80, 480.e1-8.

Indeksirano‎: PubMed 16935098

DOI‎: 10.1016/j.jtcvs.2006.01.064

https://www.ncbi.nlm.nih.gov/pubmed/16935098 (odpre novo okno)

Tranexamic acid in patients undergoing coronary-artery surgery. (odpre novo okno)

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Vir‎: N Engl J Med 2017;376(2):136-48.

Indeksirano‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (odpre novo okno)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (odpre novo okno)

Nurözler F, Kutlu T, Küçük G.

Vir‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Indeksirano‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (odpre novo okno)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (odpre novo okno)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Vir‎: JAMA Surg 2013;148(6):538-47.

Indeksirano‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (odpre novo okno)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (odpre novo okno)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Vir‎: JAMA. 2022;328(4):336-47.

Indeksirano‎: PubMed 35881121

DOI‎:  10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (odpre novo okno)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (odpre novo okno)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Vir‎: Anesth Analg 2012;115(2):239-43.

Indeksirano‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (odpre novo okno)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (odpre novo okno)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Vir‎: Ann Thorac Surg 2010;89(5):1489-95.

Indeksirano‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (odpre novo okno)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (odpre novo okno)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Vir‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Indeksirano‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (odpre novo okno)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (odpre novo okno)

Ballen J, Raabe M, Muirhead B.

Vir‎: Can J Anaesth 2006;53(4):353-6.

Indeksirano‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (odpre novo okno)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (odpre novo okno)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Vir‎: Transfusion 2013;53(4):798-804.

Indeksirano‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (odpre novo okno)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (odpre novo okno)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Vir‎: Ann Thorac Surg 2008;85(3):836-44.

Indeksirano‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (odpre novo okno)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (odpre novo okno)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Vir‎: Can J Cardiol 2011;27(6):869.e7-8.

Indeksirano‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (odpre novo okno)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (odpre novo okno)

Flynn BC, Steiner ME, Mazzeffi M

Vir‎: Anesthesiology. 2023 1;139(2):197-210.

Indeksirano‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (odpre novo okno)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (odpre novo okno)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Vir‎: Circulation 2009;120(1):21-7.

Indeksirano‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (odpre novo okno)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (odpre novo okno)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Vir‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Indeksirano‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (odpre novo okno)

Off-label use of recombinant human factor VIIa. (odpre novo okno)

Goodnough LT, Levy JH.

Vir‎: Ann Thorac Surg 2014;98(2):393-5.

Indeksirano‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (odpre novo okno)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (odpre novo okno)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Vir‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Indeksirano‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (odpre novo okno)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (odpre novo okno)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Vir‎: Circulation 2008;118(4):331-8.

Indeksirano‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (odpre novo okno)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (odpre novo okno)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Vir‎: J Vasc Surg 2011;53(4):1032-7.

Indeksirano‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (odpre novo okno)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (odpre novo okno)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Vir‎: Transfus Med Hemother 2012;39(2):139-50.

Indeksirano‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (odpre novo okno)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (odpre novo okno)

Lehr EJ, Alford TJ, Wang SH.

Vir‎: Heart Surg Forum 2010;13(5):E275-9.

Indeksirano‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (odpre novo okno)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (odpre novo okno)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Vir‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Indeksirano‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (odpre novo okno)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (odpre novo okno)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Vir‎: Drugs R D 2015;15(2):187-94.

Indeksirano‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (odpre novo okno)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (odpre novo okno)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Vir‎: A A Case Rep 2015;5(1):3-5.

Indeksirano‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (odpre novo okno)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (odpre novo okno)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Vir‎: Anesthesiology 2003;98(6):1513-5.

Indeksirano‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (odpre novo okno)

Recombinant activated factor VII in cardiac surgery: a systematic review. (odpre novo okno)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Vir‎: Ann Thorac Surg 2007;83(2):707-14.

Indeksirano‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (odpre novo okno)

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (odpre novo okno)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Vir‎: Transfusion 2014;54(5):1348-57.

Indeksirano‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (odpre novo okno)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (odpre novo okno)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Vir‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Indeksirano‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (odpre novo okno)

Reducing blood transfusion in aortic surgery: a novel approach. (odpre novo okno)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Vir‎: Ann Thorac Surg 2019;108(5):1369-75.

Indeksirano‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (odpre novo okno)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (odpre novo okno)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Vir‎: Ann Thorac Surg 2009;88(5):1666-8.

Indeksirano‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (odpre novo okno)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (odpre novo okno)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Vir‎: Crit Care 2016;20:5.

Indeksirano‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (odpre novo okno)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (odpre novo okno)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Vir‎: A A Case Rep 2015;4(10):140-2.

Indeksirano‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (odpre novo okno)

State of the art - how I manage coagulopathy in cardiac surgery patients. (odpre novo okno)

Davidson S.

Vir‎: Br J Haematol 2014;164(6):779-89.

Indeksirano‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (odpre novo okno)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (odpre novo okno)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Vir‎: Anesthesiology 2011;115(6):1179-91.

Indeksirano‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (odpre novo okno)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (odpre novo okno)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Vir‎: JAMA Netw Open 2021;4(4):e213936.

Indeksirano‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (odpre novo okno)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (odpre novo okno)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Vir‎: Thromb Haemost 2009;102(1):137-44.

Indeksirano‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (odpre novo okno)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (odpre novo okno)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Vir‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Indeksirano‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (odpre novo okno)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (odpre novo okno)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Vir‎: Anesthesiology 2013;118(1):40-50.

Indeksirano‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (odpre novo okno)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (odpre novo okno)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Vir‎: J Am Heart Assoc 2015;4(6):e002066.

Indeksirano‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (odpre novo okno)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (odpre novo okno)

Ranucci M, Baryshnikova E.

Vir‎: Br J Anaesth 2016;116(5):618-23.

Indeksirano‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (odpre novo okno)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (odpre novo okno)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Vir‎: Can J Anaesth 2012;59(3):299-303.

Indeksirano‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (odpre novo okno)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (odpre novo okno)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Vir‎: Ann Thorac Surg 2019;107(4):1275-83.

Indeksirano‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (odpre novo okno)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (odpre novo okno)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Vir‎: Anesth Analg 2007;104(4):763-5.

Indeksirano‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (odpre novo okno)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (odpre novo okno)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Vir‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indeksirano‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (odpre novo okno)

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (odpre novo okno)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Vir‎: Anaesthesia 2010;65(7):688-91.

Indeksirano‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (odpre novo okno)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (odpre novo okno)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Vir‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Indeksirano‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (odpre novo okno)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (odpre novo okno)

Wademan BH, Galvin SD.

Vir‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Indeksirano‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (odpre novo okno)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (odpre novo okno)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Vir‎: Anesth Analg 2010;110(3):702-7.

Indeksirano‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (odpre novo okno)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (odpre novo okno)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Vir‎: Ann Surg 2010;251(2):217-28.

Indeksirano‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (odpre novo okno)

A review of topical hemostatic agents for use in cardiac surgery. (odpre novo okno)

Barnard J, Millner R.

Vir‎: Ann Thorac Surg 2009;88(4):1377-83.

Indeksirano‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (odpre novo okno)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (odpre novo okno)

Forcillo J, Perrault LP.

Vir‎: Transfus Apher Sci 2014;50(1):26-31.

Indeksirano‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (odpre novo okno)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (odpre novo okno)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Vir‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Indeksirano‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (odpre novo okno)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (odpre novo okno)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Vir‎: Innovations (Phila) 2012;7(4):229-41.

Indeksirano‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (odpre novo okno)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (odpre novo okno)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Vir‎: J Card Surg 2009;24(6):722-4.

Indeksirano‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (odpre novo okno)

Topical haemostatic agents. (odpre novo okno)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Vir‎: Br J Surg 2008;95(10):1197-225.

Indeksirano‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (odpre novo okno)

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (odpre novo okno)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Vir‎: Transfus Med 2006;16(1):31-9.

Indeksirano‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (odpre novo okno)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (odpre novo okno)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Vir‎: Anesthesiology 2011;115(6):1179-91.

Indeksirano‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (odpre novo okno)

Management of hemorrhage in cardiothoracic surgery. (odpre novo okno)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Vir‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Indeksirano‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (odpre novo okno)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (odpre novo okno)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Vir‎: Anesthesiology 2012;117(3):531-47.

Indeksirano‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (odpre novo okno)